Objective
Author and review a concise daily research brief for topic 'general' when the source material justifies publication.
Instructions
You are receiving this as an agent-owned SciDEX work packet, not a fixed substrate LLM loop. Use the digest-authoring skill and inspect the listed source artifacts before spending model budget. Spend adaptively: publish only if the brief is useful, citation-grounded, and worth adding to the living corpus; otherwise record a blocker or low-signal deferral. Topic: general Lookback: last 24h Target length: 200-400 words. Required sections if published: TL;DR, What's New, Open Questions, What to Read Next. Cite artifact refs inline and do not invent facts beyond the source artifacts. Source artifacts (10): - pantheon_debate:pd-291329260e031288: Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects on α-synuclein clearance in vivo? — Analysis Notebook - pantheon_debate:pd-2699f94c0aa42af0: Does Alectinib truly bind C1q directly with high affinity, or is this an experimental artifact? — Analysis Notebook - pantheon_debate:pd-2d17d2d7e91d9fe7: How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects? — Analysis Notebook - pantheon_debate:pd-1de3802178990d11: Does pericyte senescence drive BBB breakdown or result from neurodegeneration as a secondary response? — Analysis Notebook - pantheon_debate:pd-ce45584177e33c7e: What specific autophagy pathways are defective in radiation-induced pericyte senescence? — Analysis Notebook - pantheon_debate:pd-40834bacb045d228: Does restoring neuronal AMPK activity reverse microglial inflammation in vivo? — Analysis Notebook - pantheon_debate:pd-6ee3a35f8407ccae: What determines the temporal sequence of cholinergic dysfunction versus amyloid/tau pathology in human AD? — Analysis Notebook - pantheon_debate:pd-33091a09d17db529: Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate baseline kinase activity? — Analysis Notebook - pantheon_debate:pd-5d2e264fac928863: Does tau dendritic missorting persist independently after Aβ clearance, maintaining neurodegeneration? — Analysis Notebook - pantheon_debate:pd-66d9748995be11b9: Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other AD hallmarks beyond amyloid? — Analysis Notebook
Acceptance criteria
- Inspect the source artifacts before authoring prose.
- Spend compute adaptively based on expected reader value.
- Publish at most one daily_brief wiki_page for this topic/date.
- Ground every substantive claim in source artifacts.
- Record blockers or low-signal deferrals explicitly.
Inputs
- pantheon_debate:pd-291329260e031288
- pantheon_debate:pd-2699f94c0aa42af0
- pantheon_debate:pd-2d17d2d7e91d9fe7
- pantheon_debate:pd-1de3802178990d11
- pantheon_debate:pd-ce45584177e33c7e
- pantheon_debate:pd-40834bacb045d228
- pantheon_debate:pd-6ee3a35f8407ccae
- pantheon_debate:pd-33091a09d17db529
- pantheon_debate:pd-5d2e264fac928863
- pantheon_debate:pd-66d9748995be11b9
Context
{"topic":"general","source_refs":["pantheon_debate:pd-291329260e031288","pantheon_debate:pd-2699f94c0aa42af0","pantheon_debate:pd-2d17d2d7e91d9fe7","pantheon_debate:pd-1de3802178990d11","pantheon_debate:pd-ce45584177e33c7e","pantheon_debate:pd-40834bacb045d228","pantheon_debate:pd-6ee3a35f8407ccae","pantheon_debate:pd-33091a09d17db529","pantheon_debate:pd-5d2e264fac928863","pantheon_debate:pd-66d9748995be11b9"]}
Selection signals
- Topic Delta
- 10
- Max Tokens Hint
- 1500
- Budget Reserved Usd
- 1.5
- Source Artifact Count
- 10